GLP-1 drugs like Ozempic may help clear Alzheimer’s disease plaques, new systematic review suggests

Deep sleep brain waves during NREM offer protection against Alzheimer’s disease, suggesting that sleep quality may help counteract the cognitive risks associated with elevated levels of the neurotransmitter orexin

Among 28,720 People With Type 2 Diabetes, Women Were More Likely to Develop Mental Health Conditions, While Men More Often Developed Cardiovascular and Kidney Disease

Conceptual shift in TBI classification from the Glasgow Coma Scale to a new framework that integrates clinical and imaging features, biomarkers, and modifiers to improve disease characterization and describe disease trajectories

GLP-1 weight loss drugs such as Ozempic are linked with a lower risk of age‐related macular degeneration (AMD), a common eye disease that is the leading cause of irreversible vision loss in older adults.

The mRNA-LNP vaccine encoding viral VP2 confers effective protection against novel variant infectious bursal disease virus (nVarIBDV)

Show HN: 35k+ paper psychedelic library that knows LSD from Lumpy Skin Disease

Depression is linked to a smaller volume in a memory-related hippocampal region, according to brain scans of 2,009 cognitively healthy adults aged 50–90, independent of body mass index, physical activity, and several major biological indicators of Alzheimer's disease risk.

Researchers found a "genetic switch" that triggers neurodegeneration in both a rare childhood dementia and Alzheimer's disease due to waste build-up in microglia

Unexpected structure detected in the brains of humans and mice with Alzheimer’s disease - scientists pinpointed an entirely new pathological basis for the disease: an accumulation of mitochondrial plaques, due to the brain's inability to recycle its failing mitochondria.